Fig. 7From: Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndromeCumulative incidence of non-replase mortality (NRM) classified by MF (MF-0/1 VS. MF-2/3)Back to article page